C allele of the rs2209972 single nucleotide polymorphism of the insulin degrading enzyme gene and Alzheimer's disease in type 2 diabetes, a case control study

Medicina Clinica

Volumn 144, Issue 4, 2015, Pages 151-155

  Gutiérrez Hermosillo, Hugo ^a   De León González, Enrique Díaz ^a   Palacios Corona, Rebeca ^a   Cedillo Rodríguez, Javier Armando ^a   Camacho Luis, Abelardo ^b   Reyes Romero, Miguel Arturo ^b   Medina Chávez, Juan Humberto ^c   Blandón, Pedro A ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^c Paul L Foster School of Medicine   (United States)

Author keywords

Alzheimer' disease; Dementia; Elderly; Insulin degrading enzyme; Type 2 diabetes mellitus

Indexed keywords

INSULINASE; APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HOMOZYGOSITY; HUMAN; LABORATORY TEST; MALE; MEXICO; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPLICATION; EPIDEMIOLOGY; GENE FREQUENCY; GENETICS; OUTPATIENT; PSYCHOLOGY; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INSULYSIN; MALE; MEXICO; OUTPATIENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES;

EID: 84921614222     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2013.09.035     Document Type: Article

References (35)

1. M.A. Lovell, and W.R. Markesberry Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease Nucleic Acids Res 35 2007 7497 7504
2. J.J. Jalbert, L.A. Daiello, and K.L. Lapane Dementia of the Alzheimer type Epidemiol Rev 30 2008 15 34 10.1093/epirev/mxn008
3. T. Shamah-Levy, L. Cuevas-Nasu, V. Mundo-Rosas, C. Morales-Ruan, L. Cervantes-Turrubiates, and S. Villalpando-Hernandez Health and nutrition status of older adults in Mexico: results of a national probabilistic survey Salud Publica Mex 50 2008 383 389
4. H. Gutiérrez-Hermosillo, E. Díaz de León-González, P. Pérez-Cortez, H. Cobos-Aguilar, V. Gutiérrez-Hermosillo, and H. Eloy Tamez-Pérez Prevalence of type 2 diabetes mellitus in elderly patients and associated factors in a general hospital of the north of Mexico Gac Méd Méx 148 2012 14 18
5. T. Hornick, and D.C. Aron Preventing and managing diabetic complications in elderly patients Cleve Clin J Med 75 2008 153 158
6. J.E. Morley Diabetes and aging: epidemiologic overview Clin Geriatr Med 24 2008 395 405 v
7. J.S. Saczynski, M.K. Jonsdottir, M.E. Garcia, P.V. Jonsson, R. Peila, and G. Eiriksdottir Cognitive impairment: an increasingly important complication of type 2 diabetes: the age, gene/environment susceptibility - Reykjavik study Am J Epidemiol 168 2008 1132 1139
8. W. Farris, S. Mansourian, M.A. Leissring, E.A. Eckman, L. Bertram, and C.B. Eckman Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein Am J Pathol 164 2004 1425 1434
9. C.T. Kodl, and E.R. Seaquist Cognitive dysfunction and diabetes mellitus Endocr Rev 29 2008 494 511
10. M.C. Carrillo, A. Blackwell, H. Hampel, J. Lindborg, R. Sperling, and D. Schenk Early risk assessment for Alzheimer's disease Alzheimers Dement 5 2009 182 196
11. O. Thibault, J.C. Gant, and P.W. Landfield Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store Aging Cell 6 2008 307 317
12. R. Queralt-Monttañola Factores de riesgo genéticos y ambientales en la enfermedad de Alzheimer de presentación esporádica R. Alberca, S. Lopez-Pousa, Enfermedad de Alzheimer y otras demencias 2007 171 177 Madrid
13. J.M. Burns, J.E. Donnelly, H.S. Anderson, M.S. Mayo, L. Spencer-Gardner, and G. Thomas Peripheral insulin and brain structure in early Alzheimer disease Neurology 69 2007 1094 1104
14. E. Ronnemaa, B. Zethelius, J. Sundelof, J. Sundstrom, M. Degerman-Gunnarsson, and C. Berne Impaired insulin secretion increases the risk of Alzheimer disease Neurology 71 2008 1065 1071
15. L. Bian, J.D. Yang, T.W. Guo, Y. Sun, S.W. Duan, and W.Y. Chen Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese Neurology 63 2004 241 245
16. J.L. Cummings Alzheimer's disease N Engl J Med 351 2004 56 67
17. J.S. Miners, S. Baig, H. Tayler, P.G. Kehoe, and S. Love Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity J Neuropathol Exp Neurol 68 2009 902 914
18. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
19. J.A. Yesavage Geriatric Depression Scale Psychopharmacol Bull 24 1988 709 711
20. F.I. Mahoney, and D.W. Barthel Functional evaluation: The Barthel Index Md State Med J 14 1965 61 65
21. X. Lu, Y. Huang, Y. Liu, X. Wu, and X. Shi Variants in the insulin-degrading enzyme gene are associated with metabolic syndrome in Chinese elders Metabolism 58 2009 1465 1469
22. J.E. Hixson, and D.T. Vernier Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI J Lipid Res 31 1990 545 548
23. L.E. Botero, A.E. Toro, A.J. Patino, G. Salazar, J.C. Rodriguez, and J.C. Suarez-Escudero Diabetes mellitus in patients with Alzheimer's disease: clinical description and correlation with the APOE genotype in a sample population from the province of Antioquia, Colombia Biomedica 32 2012 239 251
24. C. Kawas, S. Gray, R. Brookmeyer, J. Fozard, and A. Zonderman Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging Neurology 54 2000 2072 2077
25. J.C. Mueller, M. Riemenschneider, A. Schoepfer-Wendels, H. Gohlke, L. Konta, and P. Friedrich Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures Neurobiol Aging 28 2007 727 734
26. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, and M.P. Frosch Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proc Natl Acad Sci USA 100 2003 4162 4167
27. A. Caccamo, S. Oddo, M.C. Sugarman, Y. Akbari, and F.M. LaFerla Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders Neurobiol Aging 26 2005 645 654
28. C. Reitz, R. Cheng, N. Schupf, J.H. Lee, P.D. Mehta, and E. Rogaeva Association between variants in IDE-KIF11-HHEX and plasma amyloid β levels Neurobiol Aging 33 2012 e113 e197
29. F. Wang, C. Shu, L. Jia, X. Zuo, Y. Zhang, and A. Zhou Exploration of 16 candidate genes identifies the association of IDE with Alzheimer's disease in Han Chinese Neurobiol Aging 33 2012 1014.e1 1014.e9 10.1016/j.neurobiolaging.2010.08.004
30. R.H. Myers, E.J. Schaefer, P.W. Wilson, R. D'Agostino, J.M. Ordovas, and A. Espino Apolipoprotein E epsilon4 association with dementia in a population-based study: the Framingham study Neurology 46 1996 673 677
31. P.J. Cui, L. Cao, Y. Wang, Y.L. Deng, W. Xu, and G. Wang The association between two single nucleotide polymorphisms within the insulin-degrading enzyme gene and Alzheimer's disease in a Chinese Han population J Clin Neurosci 19 2012 745 749 10.1016/j.jocn.2011.08.036
32. J.S. Miners, S. Baig, H. Tayler, P.G. Kehoe, and S. Love Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity J Neuropathol Exp Neurol 68 2009 902 914 10.1097/NEN.0b013e3181afe475
33. E. Lazcano-Ponce, E. Salazar-Martinez, and M. Hernandez-Avila Case-control epidemiological studies: theoretical bases, variants and applications Salud Publica Mex 43 2001 135 150
34. F. Ostrosky-Solis, A. Ardila, M. Rosselli, G. Lopez-Arango, and V. Uriel-Mendoza Neuropsychological test performance in illiterate subjects Arch Clin Neuropsychol 13 1998 645 660
35. M.E. Blomqvist, P.A. Silburn, D.D. Buchanan, N. Andreasen, K. Blennow, and N.L. Pedersen Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease Neurogenetics 5 2004 115 119